C Luke
Overview
Explore the profile of C Luke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
438
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Roder D, Houssami N, Farshid G, Gill G, Luke C, Downey P, et al.
Breast Cancer Res Treat
. 2008 Mar;
108(3):409-16.
PMID: 18351455
Background: Efficacy of breast screening may differ in practice from the results of randomized trials. We report one of the largest case-control evaluations of a screening service. Methods: Subjects included...
12.
Luke C, Dohmen C, Dietlein T, Brunner R, Luke M, Krieglstein G
Klin Monbl Augenheilkd
. 2008 Feb;
224(12):932-4.
PMID: 18260057
Background: Guillain-Barré syndrome (GBS) is an acute inflammatory demyelinating disease of the peripheral nervous system. Treatment strategies include systemic steroids, immune adsorption, plasmapheresis, and intravenous immunoglobulins. Optic neuritis as an...
13.
Jin H, Manetz S, Leininger J, Luke C, Subbarao K, Murphy B, et al.
Vaccine
. 2007 Nov;
25(52):8664-72.
PMID: 18031873
Live attenuated influenza vaccines (LAIV) have several attributes related to safety, immunogenicity, cross-protection against antigenic drift strains, high yield and needle-free administration that make them attractive candidates for control of...
14.
Luke C, Luke M, Aisenbrey S, Dietlein T, Bartz-Schmidt K, Kirchhof B, et al.
Klin Monbl Augenheilkd
. 2007 Feb;
224(2):120-6.
PMID: 17309008
Background: The aim of the present study was to evaluate potential electrophysiological changes after 360 degrees retinotomy and macular translocation for subfoveal choroidal neovascularisation in patients with age-related macular degeneration....
15.
Selinsky C, Luke C, Wloch M, Geall A, Hermanson G, Kaslow D, et al.
Hum Vaccin
. 2006 Oct;
1(1):16-23.
PMID: 17038834
Multiple lines of evidence indicate that in the transplant population human cytomegalovirus (HCMV) infection and its associated diseases are controlled by humoral and cellular immune responses similar to those that...
16.
Luke M, Warga M, Ziemssen F, Gelisken F, Grisanti S, Schneider T, et al.
Br J Ophthalmol
. 2006 Jun;
90(9):1178-82.
PMID: 16754646
Background: Bevacizumab (Avastin) is a recombinant protein that targets vascular endothelial growth factor (VEGF). In vitro, bevacizumab inhibits VEGF induced cell proliferation and tissue factor production. Abnormal angiogenesis involving VEGF...
17.
Lam L, Logan R, Luke C
Aust Dent J
. 2006 May;
51(1):16-22.
PMID: 16669472
Background: Tongue cancer (141 ICD-9) is the most common intra-oral malignancy in Western countries. In recent decades, reported tongue cancer incidence and mortality rates have increased both in Europe and...
18.
Dietlein T, Jordan J, Dinslage S, Luke C, Krieglstein G
Klin Monbl Augenheilkd
. 2006 Mar;
223(3):225-9.
PMID: 16552655
Background: Modern cataract surgery with use of viscoelastics can induce remarkable early spikes of the intraocular pressure (IOP) in patients with glaucoma. Patients And Methods: The purpose of this prospective...
19.
Luke C, Luke M, Sickel W, Schneider T
Graefes Arch Clin Exp Ophthalmol
. 2006 Feb;
244(9):1188-90.
PMID: 16485112
Background: Dye solutions for intraoperative staining of epiretinal membranes and the internal limiting membrane improve the visualisation of these thin structures and facilitate their removal. Lately, the application of patent...
20.